Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
Implications of the Latest Expanded Label of 177Lu-PSMA-617 for Nuclear Medicine Practice. (PubMed, J Nucl Med) - Sep 25, 2026 - No abstract available 
Journal
http://www.ncbi.nlm.nih.gov/pubmed/42785945
 
Frankis G Almaguel; Ken Herrmann; Kevin Courtney; Michael A Gorin; Michael J Morris; Oliver Sartor; Scott Tagawa; Steven P Rowe
 
Sep 25, 2026
 
Prev Next